Ye · International journal of molecular sciences 2021 · narrative review · n=?

The Toxic Mechanism of Gliotoxins and Biosynthetic Strategies for Toxicity Prevention.

Cited 36 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review of preclinical and mechanistic data

PubMed 34948306 · doi:10.3390/ijms222413510 · record verified 2026-08-27

What was done

The authors reviewed literature regarding gliotoxin, a fungal epipolythiodioxopiperazine characterized by a disulfide bridge. The narrative summary evaluates its biosynthesis via the gli gene cluster and GliZ regulator, its mechanisms of cytotoxicity, putative dose-dependent applications (including plant pathogen control, HIV, and cancer), and biosynthetic strategies to mitigate toxicity in producing strains.

What was found

The abstract describes qualitative mechanistic pathways and provides no quantitative data. Gliotoxins induce cytotoxicity via macrophage immune suppression, antiangiogenesis, reactive oxygen species production causing DNA damage, enzyme inhibition causing peroxide damage, and apoptotic signaling pathways. Low doses are noted for prospective antioxidant, anti-HIV, anti-tumor, and agricultural biocontrol uses against Pythium ultimum and Sclerotinia sclerotiorum.

Why it matters

Clarifying the biosynthetic genetics and toxicological pathways of gliotoxins provides a basis for engineering less virulent fungal strains and exploring therapeutic derivatives.

Limits

As a narrative review, it contains no new empirical data or systematic quantitative synthesis. Discussed applications are primarily theoretical or bench-level, with no human clinical safety or efficacy data presented.

Cited by